These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Integrin-linked kinase is required in hypoxic mesenchymal stem cells for strengthening cell adhesion to ischemic myocardium. Song SW; Chang W; Song BW; Song H; Lim S; Kim HJ; Cha MJ; Choi E; Im SH; Chang BC; Chung N; Jang Y; Hwang KC Stem Cells; 2009 Jun; 27(6):1358-65. PubMed ID: 19489098 [TBL] [Abstract][Full Text] [Related]
4. Pre-treatment of mesenchymal stem cells with a combination of growth factors enhances gap junction formation, cytoprotective effect on cardiomyocytes, and therapeutic efficacy for myocardial infarction. Hahn JY; Cho HJ; Kang HJ; Kim TS; Kim MH; Chung JH; Bae JW; Oh BH; Park YB; Kim HS J Am Coll Cardiol; 2008 Mar; 51(9):933-43. PubMed ID: 18308163 [TBL] [Abstract][Full Text] [Related]
5. Difluoromethylornithine stimulates early cardiac commitment of mesenchymal stem cells in a model of mixed culture with cardiomyocytes. Muscari C; Bonafé F; Carboni M; Govoni M; Stanic I; Gamberini C; Ricci F; Tazzari PL; Caldarera CM; Guarnieri C J Cell Biochem; 2008 Mar; 103(4):1046-52. PubMed ID: 18240140 [TBL] [Abstract][Full Text] [Related]
6. Hypoxia increases Sca-1/CD44 co-expression in murine mesenchymal stem cells and enhances their adipogenic differentiation potential. Valorani MG; Germani A; Otto WR; Harper L; Biddle A; Khoo CP; Lin WR; Hawa MI; Tropel P; Patrizi MP; Pozzilli P; Alison MR Cell Tissue Res; 2010 Jul; 341(1):111-20. PubMed ID: 20496083 [TBL] [Abstract][Full Text] [Related]
7. Intravenous transplantation of mesenchymal stem cells improves cardiac performance after acute myocardial ischemia in female rats. Jiang W; Ma A; Wang T; Han K; Liu Y; Zhang Y; Zhao X; Dong A; Du Y; Huang X; Wang J; Lei X; Zheng X Transpl Int; 2006 Jul; 19(7):570-80. PubMed ID: 16764636 [TBL] [Abstract][Full Text] [Related]
8. 5-Azacytidine-treated human mesenchymal stem/progenitor cells derived from umbilical cord, cord blood and bone marrow do not generate cardiomyocytes in vitro at high frequencies. Martin-Rendon E; Sweeney D; Lu F; Girdlestone J; Navarrete C; Watt SM Vox Sang; 2008 Aug; 95(2):137-48. PubMed ID: 18557828 [TBL] [Abstract][Full Text] [Related]
10. Enhancement of MSC adhesion and therapeutic efficiency in ischemic heart using lentivirus delivery with periostin. Cho YH; Cha MJ; Song BW; Kim IK; Song H; Chang W; Lim S; Ham O; Lee SY; Choi E; Kwon HM; Hwang KC Biomaterials; 2012 Feb; 33(5):1376-85. PubMed ID: 22112759 [TBL] [Abstract][Full Text] [Related]
11. Bone marrow-derived mesenchymal stromal cells express cardiac-specific markers, retain the stromal phenotype, and do not become functional cardiomyocytes in vitro. Rose RA; Jiang H; Wang X; Helke S; Tsoporis JN; Gong N; Keating SC; Parker TG; Backx PH; Keating A Stem Cells; 2008 Nov; 26(11):2884-92. PubMed ID: 18687994 [TBL] [Abstract][Full Text] [Related]
12. Effect of transplanted mesenchymal stem cells from rats of different ages on the improvement of heart function after acute myocardial infarction. Wang YQ; Wang M; Zhang P; Song JJ; Li YP; Hou SH; Huang CX Chin Med J (Engl); 2008 Nov; 121(22):2290-8. PubMed ID: 19080335 [TBL] [Abstract][Full Text] [Related]
13. Impact of myocardial infarct proteins and oscillating pressure on the differentiation of mesenchymal stem cells: effect of acute myocardial infarction on stem cell differentiation. Chang SA; Lee EJ; Kang HJ; Zhang SY; Kim JH; Li L; Youn SW; Lee CS; Kim KH; Won JY; Sohn JW; Park KW; Cho HJ; Yang SE; Oh WI; Yang YS; Ho WK; Park YB; Kim HS Stem Cells; 2008 Jul; 26(7):1901-12. PubMed ID: 18403756 [TBL] [Abstract][Full Text] [Related]
14. The metabolism of human mesenchymal stem cells during proliferation and differentiation. Pattappa G; Heywood HK; de Bruijn JD; Lee DA J Cell Physiol; 2011 Oct; 226(10):2562-70. PubMed ID: 21792913 [TBL] [Abstract][Full Text] [Related]
15. Ex vivo pretreatment with melatonin improves survival, proangiogenic/mitogenic activity, and efficiency of mesenchymal stem cells injected into ischemic kidney. Mias C; Trouche E; Seguelas MH; Calcagno F; Dignat-George F; Sabatier F; Piercecchi-Marti MD; Daniel L; Bianchi P; Calise D; Bourin P; Parini A; Cussac D Stem Cells; 2008 Jul; 26(7):1749-57. PubMed ID: 18467662 [TBL] [Abstract][Full Text] [Related]
16. Effect of 5-azacytidine: evidence for alteration of the multipotent ability of mesenchymal stem cells. Rosca AM; Burlacu A Stem Cells Dev; 2011 Jul; 20(7):1213-21. PubMed ID: 21067364 [TBL] [Abstract][Full Text] [Related]
17. Endogenous glycogen prevents Ca2+ overload and hypercontracture in harp seal myocardial cells during simulated ischemia. Henden T; Aasum E; Folkow L; Mjøs OD; Lathrop DA; Larsen TS J Mol Cell Cardiol; 2004 Jul; 37(1):43-50. PubMed ID: 15242734 [TBL] [Abstract][Full Text] [Related]
18. The roles of mesenchymal stem cells (MSCs) therapy in ischemic heart diseases. Wang XJ; Li QP Biochem Biophys Res Commun; 2007 Jul; 359(2):189-93. PubMed ID: 17543286 [TBL] [Abstract][Full Text] [Related]
19. Survival, neuron-like differentiation and functionality of mesenchymal stem cells in neurotoxic environment: the critical role of erythropoietin. Danielyan L; Schäfer R; Schulz A; Ladewig T; Lourhmati A; Buadze M; Schmitt AL; Verleysdonk S; Kabisch D; Koeppen K; Siegel G; Proksch B; Kluba T; Eckert A; Köhle C; Schöneberg T; Northoff H; Schwab M; Gleiter CH Cell Death Differ; 2009 Dec; 16(12):1599-614. PubMed ID: 19609278 [TBL] [Abstract][Full Text] [Related]
20. Adipose tissue and bone marrow-derived stem cells react similarly in an ischaemia-like microenvironment. Tse KH; Kingham PJ; Novikov LN; Wiberg M J Tissue Eng Regen Med; 2012 Jun; 6(6):473-85. PubMed ID: 21751425 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]